UNCY · Unicycive Therapeutics, Inc.
$5.45
-0.13 (-2.33%)
At close · Aug 20
Market Cap
$151.81M
Shares
27.86M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| 8-K | 2026-07-02 | — | |
| 8-K | 2026-06-22 | 2026-06-19 | |
| 8-K | 2026-06-05 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-19 | |
| 8-K | 2026-04-06 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2025-11-14 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-28 | — | |
| 8-K | 2025-08-18 | 2025-08-15 | |
| 8-K | 2025-08-15 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-08 | 2025-07-07 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-20 | 2025-06-17 | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-05-21 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-30 | 2025-06-09 | |
| 8-K/A | 2025-04-14 | 2024-03-13 | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-01-07 | — | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-09-25 | 2024-09-24 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-07-15 | 2024-07-09 | |
| 8-K | 2024-07-15 | 2024-07-09 | |
| 8-K | 2024-07-02 | 2024-06-26 | |
| 8-K | 2024-06-26 | 2024-06-21 | |
| 8-K | 2024-06-25 | — | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-05-13 | — | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-20 | |
| 8-K | 2024-03-29 | 2024-03-28 | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-03-14 | 2024-03-13 |
Showing 1–50 of 95 filings
Key facts
CIK
1766140
CUSIP
90466Y202
13F (30d)
81 filings
79 filers
Visit website
Investor relations